Given that lncRNAs can be targeted therapeutically by nucleic acid-based mimics and inhibitors, our findings suggest that modulation of DINO activity may have therapeutic value by restoring TP53 tumor suppressor activity in some tumor types, including HPV-positive tumors. Here, TP53 is linked to neoplasm.